Showing results (11-20 of 29) with videos related to
Sort By:
Pageof 3
Viruses|June 6, 2019
Pathogenesis of Respiratory Syncytial Virus Infection in BALB/c Mice Differs Between Intratracheal and Intranasal InoculationElisabeth A van Erp, Anke J Lakerveld, H Lie Mulder, et al.Human Vaccines & Immunotherapeutics|March 10, 2015
Safety and immunogenicity of influenza whole inactivated virus vaccines: A phase I randomized clinical trialRenée A J van Boxtel, Pauline Verdijk, Otto J de Boer, et al.The Journal of Infectious Diseases|September 26, 2018
Respiratory Syncytial Virus Infects Primary Neonatal and Adult Natural Killer Cells and Affects Their Antiviral Effector FunctionElisabeth A van Erp, Dorien Feyaerts, Maxime Duijst, et al.Pathogens and Disease|May 7, 2024
Prevalence of human respiratory pathogens and associated mucosal cytokine levels in young children and adults: a cross-sectional observational study in the Netherlands during the winter of 2012/2013Puck B van Kasteren, Anne T Gelderloos, Mioara Alina Nicolaie, et al.Developmental and Comparative Immunology|January 7, 2018
Diversity of aging of the immune system classified in the cotton rat (Sigmodon hispidus) model of human infectious diseasesTeun Guichelaar, Elisabeth A van Erp, Jeroen Hoeboer, et al.Vaccine|June 14, 2012
HI responses induced by seasonal influenza vaccination are associated with clinical protection and with seroprotection against non-homologous strainsWillem Luytjes, Vincent Enouf, Maarten Schipper, et al.Journal of Virology|April 22, 2016
Characterization of Epitope-Specific Anti-Respiratory Syncytial Virus (Anti-RSV) Antibody Responses after Natural Infection and after Vaccination with Formalin-Inactivated RSVIvy Widjaja, Oliver Wicht, Willem Luytjes, et al.Journal of Virology|August 11, 2017
<i>In Vitro</i> Enhancement of Respiratory Syncytial Virus Infection by Maternal Antibodies Does Not Explain Disease Severity in InfantsElisabeth A van Erp, Puck B van Kasteren, Teun Guichelaar, et al.Journal of Virology|June 13, 2014
Impaired immune response to vaccination against infection with human respiratory syncytial virus at advanced ageTeun Guichelaar, Jeroen Hoeboer, Myra N Widjojoatmodjo, et al.Plos One|January 31, 2017
Characteristics of RSV-Specific Maternal Antibodies in Plasma of Hospitalized, Acute RSV Patients under Three Months of AgeJop Jans, Oliver Wicht, Ivy Widjaja, et al.Pageof 3